Member Info for Globalcrossings

LONDON (Dow Jones)--Supercart PLC (SC.LN), a U.K. company involved in the design, marketing and distribution of plastic shopping trolleys, said Thursday it has received further substantial orders through its European distribution partner, Caddie SA. MAIN FACTS: -Supercart has now received a further two orders for immediate delivery, through Caddie, with an aggregate value of over GBP600,000. -Shares closed at 10.5 pence on Wednesday. -By Elliott Ball, Dow Jones Newswires; 44-20-7842-9314; elliott.ball@dowjones.com (END) Dow Jones Newswires April 08, 2010 02:23 ET (06:23 GMT)

Online advertising specialist Burst Media recovered from a bad first quarter to record year on year growth of 77% in media sales in the final quarter of 2009. Total revenue for the year rose to $31.4m from $27.3m in 2008, but losses before tax widened to $0.75m from $0.20m the year before. In a separate announcement said it has acquired On The Phone Media (OTP), a leading premium advertising network in the UK, for an initial consideration of £1.58m, plus 1m new Burst common shares. A further £1.1m and another 2m new Burst shares may become payable depending on whether OTP hits certain financial targets.

Yes, I'm in... I see some potential for some real growth in the future... GL

LONDON (Dow Jones)--Siteserv PLC (SSV.LN) said Wednesday that through its subsidiary Sierra Communications Limited, a services provider to the telecommunications, power & energy and civil engineering sectors, it has signed a contract worth up to EUR60 million to become the sole services provider associated with the installation, maintenance and testing of domestic boilers and a range of energy efficient products and services to Bord Gais Energy. MAIN FACTS: -Sierra will incorporate the existing Bord Gais Energy Appliance Servicing business into a new division which will initially employ 20 new full time staff in the areas of management and administration. -In addition to a number of subcontracted staff who will transfer to the new division, the company will also create a further 70 building services jobs over the next 12 months. -Separately, Sierra will also expand its services into the North of Ireland, establishing an office in this market. -The contract was secured in a competitive tender process, in which both international and Irish companies participated. -The contract has an estimated value of up to EUR60 million over the 3-year term and has a potential to extend for a further 2 years potentially bringing the value to EUR100 million in total. -Shares closed Tuesday at 5.0 pence. -By Iain Packham, Dow Jones Newswires; 44-20-7842-9269; iain.packham@dowjones.com (END) Dow Jones Newswires April 07, 2010 02:39 ET (06:39 GMT)

LONDON (Dow Jones)--Discovery Metals Limited (DME.LN), said Wednesday that total Boseto Mineral Resource increased to 102.8 Mt at 1.4% copper and 17.3 g/t silver. MAIN FACTS: -Total Mineral Resources at Boseto increased by 68% from September 2009 -Contained copper in Mineral Resources at Boseto increased by 68% to 1.422 million tonnes and contained silver increased by 50% to 57 million ounces -Measured and Indicated Mineral Resources have increased by 92% to 22.5Mt at 1.5% copper and 18.7 g/t silver -Total Mineral Resource tonnes at the combined Plutus and Petra increased by 270% (42.4 million tonnes) to 67.4 million tonnes at 1.4% Cu and 14.7 g/t Ag -Contained copper and contained silver increased by 254% -Measured and Indicated Mineral Resource of 11.6 Mt at 1.4% copper and 14.1 g/t silver -Inferred Mineral Resource increased to 55.8 Mt at 1.4% copper and 14.8 g/t silver -Includes addition of North East Plutus and South West Petra Prospects into the Mineral Resource Estimate -Strike length of the combined Plutus and Petra Mineral Resources exceeds 25 kilometres and remains open to the north east -Bankable Feasibility Study technical reports received by end of March and being reviewed by Discovery Metals management -Boseto Copper Project remains on track for first production in late 2011, subject to receipt of internal and external approvals in Q2. -Shares closed Tuesday at 46.50 pence. -By Razak Musah Baba, Dow Jones Newswires; +44-20-7842-9275; razak.baba@dowjones.com (END) Dow Jones Newswires April 07, 2010 01:57 ET (05:57 GMT)

RNS Number : 7582J Crimson Tide PLC 07 April 2010    Crimson Tide Plc ("Crimson Tide" or the "Company") CRIMSON TIDE TECHNOLOGY KEEPS IRISH GOVERNMENT PROJECT SECURE Crimson Tide, the mobile software technologies company, is pleased to announce that a ten year study initiated by the Irish Government to ensure that the needs of its older people are met, is utilising an advanced mobile system developed by the Company to guarantee security and confidentiality.  TILDA (The Irish LongituDinal Study on Ageing) was launched by Minister for Health Mary Harney in November 2006, to study a representative sample of at least 8,000 people, aged 50 years and over and resident in Ireland. It charts their health, social and economic circumstances over a 10-year period. The study is being carried out across the whole of Ireland by Trinity College Dublin in collaboration with a panel of scientific researchers and international scientists with expertise in various fields of ageing.   Crimson Tide's system ensures this operation is carried out in a secure and confidential manner using mobile portable technology.  The application is centred around the Motorola MC55 hand held device and requires the user to identify and capture each respondent's details.  It enables the user to move through a series of screens, adding additional data relevant to the project, as they proceed.   The system uses real time GPRS data transfer to ensure that records are updated immediately after each visit, and the hand held device interacts with a number of application-based tests carried out on a laptop computer.  All information gathered is kept strictly confidential and used only for research purposes. Says Dr Hilary Cronin, Medical Director for TILDA: "Crimson Tide is an exceptional company to work with and I cannot recommend them highly enough. Their people are incredibly efficient and so pleasant to deal with.  They spent time ensuring that our technology interfaces were user friendly and intuitive.  Our initially 'techno-phobic' research nurses now love their PDA's and can't imagine collecting data without them! It has significantly improved the way we conduct our clinical research. Their technologies are now an integral part of our study and I look forward to working with them again in the future." Crimson Tide Director Laurence Darcy says: "It has been a privilege to work on this study with Trinity College Dublin to develop a state-of-the art mobile data solution. We are working on a range of solutions in the healthcare sector and expect to have more innovative solutions coming to the market this year." - ends - For further information, contact: Crimson Tide plc Barrie Whipp, Executive Chairman   01892 542 444 Threadneedle Communications Graham Herring/Josh Royston   020 7653 9850   This information is provided by RNS The company news service fr

I could not resist... A nice little top up again @ .32... GLA

http://www.screencast.com/users/globalcrossings/folders/Jing/media/8de8fb50-3344-4d6e-a7c5-b0193706ca0d

To jump in but hate to do so on such a rise... With that said, a very interesting company for a mid-long position. GLA

Code: ERU Share Price: 0.8 pence Market Cap: £1.5 million Website http://www.erumaplc.com Incorporated in March 2005 and listed on AIM in July 2005, Eruma plc is the holding company for Illuminex Ltd and Security Blinds Ltd. Illuminex Ltd is a supplier and distributor of intelligent lighting systems. Illuminex solid state systems provide superior performance whilst reducing costs to businesses through reductions in energy consumption and maintenance overhead. Security Blinds Ltd is a leading manufacturer of physical security and protection systems in the UK. Servicing both the public and commercial sectors, the patented Secur™ system provides clients with protection against theft and forced entry. The system also gives businesses and institutions the opportunity to take proactive steps to address the modern threat of terrorism; having met stringent testing requirements to win endorsement by the Home Office, Association of Chief Police Officers, leading banks, and local authorities through its ability to protect people, property and equipment from bomb blasts. To see a video of the security blinds on impact, please follow this link. Security Blinds Demo Launched in 2009, Security Blinds Ltd also produces the unique Anti Ram Raid Gate. This gate is installed behind roller shutters to protect against ram raids: Anchored to the inside of the building the retractable barrier resists being rammed by vehicles – including lorries – and will prevent roller shutters from being forced open by jacks or breached by angle grinders used by determined thieves. The Company has a memorandum of understanding with Pentagon Protection, an AIM traded global specialist in the supply and installation of enhanced glass protection, which will see the formation of a strategic partnership between Eruma and Pentagon, that will aim to jointly develop business globally within the counter terrorism and environmental protection markets which are worth in excess of £30 billion per annum. Whilst Eruma has been a loss-making business up until now, it plans to be operationally profitable in 2010 and to take advantage of large scale opportunities open to the business. Certainly 2010 seems to have started well. The Company has issued two positive trading updates in February in connection with Anti Ram Raid Gates and Illuminex Lighting.

TIDMAGR RNS Number : 7079J Assura Group Limited 06 April 2010 ? Assura Group Limited ("Assura" or the "Company") Statement re Possible Offer The Board of Assura announced on 15 January 2010 that it was in preliminary discussions that may or may not result in an offer being made for the Company. These discussions have now been terminated and the parties from whom approaches were received have confirmed that they do not intend to pursue a possible offer for the Company. For the purposes of the City Code on Takeovers and Mergers the Company is no longer considered to be in an offer period. Ends Enquiries: +-----------------------------------+-------------------------+ | Assura Group | Tel: 020 7107 3800 | | Nigel Rawlings/Conor Daly | | | | | +-----------------------------------+-------------------------+ | Cenkos Securities | Tel: 020 7397 8900 | | Ian Soanes/Beth McKiernan | | | | | +-----------------------------------+-------------------------+ | Investec Investment Banking | Tel: 020 7597 5970 | | Gary Clarence/Daniel Adams | | | | | +-----------------------------------+-------------------------+ | Financial Dynamics | Tel: 020 7831 3113 | | Juliet Edwards | | +-----------------------------------+-------------------------+ This information is provided by RNS The company news service from the London Stock Exchange END OFDSSUEEIFSSEDL (END) Dow Jones Newswires April 06, 2010 02:00 ET (06:00 GMT)

Dude... Just to let you know my friend... I did do a small top up yesterday @ .36p. Now... Can you go and buy me a few cold beers and deliver them to my house. I'm painting at the moment and feeling a bit thirsty!

http://www.screencast.com/users/globalcrossings/folders/Jing/media/8f8bbf3c-2fed-438c-82af-1e372ef05271

GLA...

LONDON (Dow Jones)--Life assurance holding company Chesnara PLC (CSN.LN) Wednesday increased its final dividend after posting a massive increase in full-year pretax profit, boosted by the Swedish company it acquired at a significant discount to embedded value last year. Chesnara is the owner of life assurance subsidiary Countrywide Assured PLC. It also bought Swedish life insurance company Moderna Liv in July and said it was looking at further acquisition opportunities. For the year ended Dec. 31, Chesnara posted pretax profit on an International Financial Reporting Standards basis of GBP44.7 million, compared with GBP22.7 million in 2008. Of this, GBP25.1 million of profit came from the Moderna acquisition. The company said its pretax profit on an European Embedded Value, or EEV basis--a key valuation measure used in the insurance industry--stood at GBP78.2 million, up from GBP14.8 million a year earlier. Analysts had predicted 2009 pretax profit of between GBP22.3 million and GBP44.9 million, according to data from the company. Chesnara increased its final dividend to 10.3 pence a share from 10.05 pence last year, taking the total dividend for the year up 2.6% to 15.95 pence. Company Web site: www.chesnara.co.uk -By Rachael Gormley, Dow Jones Newswires; 44-20-7842-9308; rachael.gormley@dowjones.com (END) Dow Jones Newswires March 31, 2010 02:24 ET (06:24 GMT)

TIDMASTR RNS Number : 4731J Astaire Group Plc 31 March 2010 ? Not for release, publication or distribution in whole or in part into any jurisdiction where to do so would constitute a violation of the relevant laws of such jurisdiction 31 March 2010 Offer by Astaire Securities Plc on behalf of Astaire Group Plc to acquire Hoodless Brennan Holdings Plc Astaire has received acceptances for 80.04% of the issued share capital: Offer Extended On 10 February 2010, Astaire Securities Plc on behalf of Astaire Group PLC ("Astaire") announced an offer to acquire the entire issued, and to be issued, share capital of Hoodless Brennan Holdings Plc ("HBH") (the "Offer"). Astaire is now pleased to announce that as at 1.00 p.m. (London time) on 30 March 2010 (being the first closing date of the Offer), Astaire had received valid acceptances in respect of 85,123,305 HBH Shares representing 80.04 per cent. of the current issued share capital of HBH. Extension of Offer Period The Board of Astaire announces that the Offer, which remains subject to the terms and conditions set out or referred to in the Offer Document, is being extended and will remain open for acceptance until the next closing date which will be 1.00 p.m. (London time) on 20 April 2010. Acceptance Procedure To accept the Offer you should complete, sign and return the Form of Acceptance (together with your share certificate(s) and any other documents of title) as soon as possible and, in any event, so as to be received by no later than 1.00 p.m. (London time) on 20 April 2010 by Share Registrars, Suite E, 9 Lion and Lamb Yard, Farnham, Surrey GU9 7LL. Further details of the acceptance procedure can be found in the Offer Document. Copies of the Offer Document, the Form of Acceptance are available on Astaire's website, www.astairegroup.co.uk/HBH-Offer.html, and from the offices of Astaire Securities Plc, 30 Old Broad Street, London EC2N 1HT during normal business hours on any business day throughout the period during which the Offer remains open for acceptance. If the Offer becomes or is declared unconditional in all respects and if sufficient acceptances are received, Astaire intends to apply the provisions of sections 979 to 982 (inclusive) of the 2006 Act to acquire compulsorily any remaining HBH Shares. Interests in Relevant Securities Save as disclosed above, neither Astaire nor any of the directors of Astaire, nor, so far as the directors of Astaire are aware, any person acting in concert with Astaire for the purposes of the Offer has any interest in, right to subscribe for, or has borrowed or lent any HBH Shares or securities convertible or exchangeable into HBH Shares ("HBH Securities"), nor does any such person have any short position (whether conditional or absolute and whether in money or otherwise), including any short position under a derivative, any agreement to sell or any delivery obligation or right to require another person to purchase or take d

http://www.antisoma.com/asm/media/attract1/

http://www.investorschronicle.co.uk/Companies/ByEvent/Regulatory/Analysis/article/20100330/4cb60ab2-3b24-11df-bddf-0015171400aa/Biotech-curse-strikes-again.jsp

By Jason Douglas Of DOW JONES NEWSWIRES http://online.wsj.com/article/BT-CO-20100329-701344.html?mod=WSJ_World_MIDDLEHeadlinesEurope LONDON (Dow Jones)--Biotechnology company Antisoma PLC (ASM.LN) Monday said partner Novartis AG (NOVN.VX) will likely reconsider testing experimental cancer medicine ASA404 in other types of cancer following its failure in a lung cancer trial. Antisoma said Monday a trial of ASA404 in lung cancer has been stopped after an interim analysis suggested it wouldn't work. Chief Executive Officer Glyn Edwards told Dow Jones Newswires a trial of ASA404 in lung cancer patients for whom another therapy has failed will continue, but Novartis will be unlikely to pursue clinical trials in breast and other cancers. The failure of ASA404 is "a significant setback," Edwards said. The London-based company, which was scheduled to receive as much as $890 million if ASA404 hit clinical and sales targets, will now focus its efforts on AS1413 and AS1411, two experimental medicines for types of leukemia, he added. Edwards said the company will review its costs and will likely trim spending on earlier stage research in favor of focusing on these two more advanced programs. The company has roughly GBP45 million in cash. Acquisitions and in-licensing activities are now effectively off the table, he said. Company Web site: www.antisoma.com -By Jason Douglas, Dow Jones Newswires; 44-20-7842-9272; jason.douglas@dowjones.com

http://www.screencast.com/users/globalcrossings/folders/Jing/media/2dbfc7f8-7df8-403d-bfe3-45602cd12e3a